Polyclonal antibodies to a fluorescent 4-hydroxy-2-nonenal (HNE)-derived lysine-lysine cross-link: Characterization and application to HNE-treated protein and in vitro oxidized low-density lipoprotein

Chemical Research in Toxicology

Volumn 13, Issue 5, 2000, Pages 406-413

  Xu, Guozhang ^a   Liu, Yahua ^a   Sayre, Lawrence M ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; LYSINE; OXIDIZED LOW DENSITY LIPOPROTEIN; POLYCLONAL ANTIBODY;

ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE; OXIDATION; PROTEIN CROSS LINKING; PROTEIN DEGRADATION; SPECTRAL SENSITIVITY;

EID: 0034034942     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx990200s     Document Type: Article

References (32)

1. Esterbauer, H., Dieber-Rotheneder, M., Waeg, G., Striegl, G., and Jurgens, G. (1990) Biochemical, structural, and functional properties of oxidized low-density lipoprotein. Chem. Res. Toxicol. 3, 77-92.
2. Goldstein, J. L., and Brown, M. S. (1977) The low-density lipoprotein pathway and its relation to atherosclerosis. Annu. Rev. Biochem. 46, 897-930.
3. Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C., and Witztum, J. L. (1989) Beyond cholesterol. Modification of low-density lipoprotein that increases its atherogenicity. N. Engl. J. Med. 320, 915-924.
4. Esterbauer, H., Zollner, H., and Schaur, R. J. (1990) Aldehydes formed by lipid peroxidation; Mechanisms of formation, occurrence and determination. In Membrane Lipid Oxidation (Vigo-Pelfrey, C., Ed.) pp 239-283, CRC Press, Boca Raton, FL.
5. Esterbauer, H., Schaur, R. J., and Zollner, H. (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde, and related aldehydes. Free Radical Biol. Med. 11, 81-128.
6. Jurgens, G., Lang, J., and Esterbauer, H. (1986) Modification of human low-density lipoprotein by the lipid peroxidation product 4-hydroxynonenal. Biochim. Biophys. Acta 875, 103-114.
7. Hoff, H. F., and O'Neil, J. (1993) Structural and functional changes in LDL after modification with both 4-hydroxynonenal and malondialdehyde. J. Lipid Rex. 34, 1209-1217.
8. Hoff, H. F., O'Neil, J., Chisolm, G. M., III, Cole, T. B., Quehenberger, O., Esterbauer, H., and Jurgens, G. (1989) Modification of low-density lipoprotein with 4-hydroxynonenal induces uptake by macrophages. Arteriosclerosis 9, 538-549.
9. Esterbauer, H., Jurgens, G., Quehenberger, O., and Koller, E. (1987) Autoxidation of human low-density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J. Lipid Res. 28, 495-509.
10. Hoff, H. F., Whitaker, T. E., and O'Neil, J. (1992) Oxidation of low-density lipoprotein leads to particle aggregation and altered macrophage recognition. J. Biol. Chem. 267, 602-609.
11. Montine, T. J., Amarnath, V., Martin, M. E., Strittmatter, W. J., and Graham, D. G. (1996) E-4-Hydroxy-2-nonenal is cytotoxic and cross-links cytoskeletal proteins in P19 neuroglial cultures. Am. J. Pathol. 148, 89-93.
12. Montine, T. J., Huang, D. Y., Valentine, W. M., Amarnath, V., Saunders, A., Weisgraber, K. H., Graham, D. G., and Strittmatter, W. J. (1996) Cross-linking of apolipoprotein E by products of lipid peroxidation. J. Neuropathol. Exp. Neurol. 55, 202-210.
13. Friguet, B., Stadtman, E. R., and Szweda, L. I. (1994) Modification of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. Formation of cross-linked protein that inhibits the multicatalytic protease. J. Biol. Chem. 269, 21639-21643.
14. Kikugawa, K., and Beppu, M. (1987) Involvement of lipid oxidation products in the formation of fluorescent and cross-linked proteins. Chem. Phys. Lipids 44, 277-296.
15. Esterbauer, H., Koller, E., Slee, R. G., and Koster, J. F. (1986) Possible involvement of the lipid-peroxidation product 4-hydroxy-nonenal in the formation of fluorescent chromolipids. Biochem. J. 239, 405-409.
16. Friguet, B., and Szweda, L. I. (1997) Inhibition of the multicatalytic proteinase (proteasome) by 4-hydroxy-2-nonenal cross-linked protein. FEBS Lett. 405, 21-25.
17. Uchida, K., and Stadtman, E. R. (1993) Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydrogenase. J. Biol. Chem. 268, 6388-6393.
18. Nadkarni, D. V., and Sayre, L. M. (1995) Structural definition of early lysine and histidine adduction chemistry of 4-hydroxynonenal. Chem. Res. Toxicol. 8, 284-291.
19. Cohn, J. A., Tsai, L., Friguet, B., and Szweda, L. I. (1996) Chemical characterization of a protein-4-hydroxy-2-nonenal cross-link: Immunochemical detection in mitochondria exposed to oxidative stress. Arch. Biochim. Biophys. 328, 158-164.
20. Xu, G., and Sayre, L. M. (1998) Structural characterization of a 4-hydroxy-2-alkenal-derived fluorophore that contributes to lipoperoxidation-dependent protein cross-linking in aging and degenerative disease. Chem. Res. Taxicol. 11, 247-251.
21. Xu, G., Liu, Y., and Sayre, L. M. (1999) Independent synthesis, solution behavior, and studies on the mechanism of formation of a primary amine-derived fluorophore representing cross-linking of proteins by (E)-4-hydroxy-2-nonenal (HNE). J. Org. Chem. 64, 5732-5745.
22. α-hippuryllysine: a model for fluorophores derived from protein modifications by lipid peroxidation. J. Org. Chem. 63, 185-187.
23. Xu, G., Liu, Y., Kansal, M. M., and Sayre, L. M. (1999) Rapid cross-linking of proteins by 4-ketoaldehydes and 4-hydroxy-2-alkenals does not arise from the lysine-derived monoalkylpyrroles. Chem. Res. Toxicol. 12, 855-861.
24. Xu, G. (1999) Modification of proteins by neurotoxic and lipoxidation-derived carbonyl compounds. Ph.D. Dissertation, Case Western Reserve University, Cleveland, OH.
25. Sayre, L. M., Sha, W., Xu, G., Kaur, K., Nadkarni, D., Subbanagounder, G., and Salomon, R. G. (1996) Immunochemical evidence supporting 2-pentylpyrrole formation on proteins exposed to 4-hydroxy-2-nonenal. Chem. Res. Toxicol. 9, 1194-1201.
26. Hoppe, G., O'Neil, J., Sayre, L. M., and Hoff, H. F. (1997) Non-conventional modification of low-density lipoproteins: Chemical models for macrophage recognition of oxidized LDL. Biochim. Biophys. Acta 1362, 103-108.
27. Hatch, F. T., and Lees, R. S. (1968) Practical methods for plasma lipoprotein analysis. Adv. Lipid Res. 6, 1-68.
28. Tsai, L., Szweda, P. A., Vinogradova, O., and Szweda, L. I. (1998) Structural characterization and immunochemical detection of a fluorophore derived from 4-hydroxy-2-nonenol and lysine. Proc. Natl. Acad. Sci. U.S.A. 95, 7975-7980.
29. t-(Carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry 34, 10872-10878.
30. Schuh, J., Fairclough, G. F., and Haschemeyer, R. H. (1978) Oxygen-mediated heterogeneity of apo-low-density lipoprotein. Proc. Natl. Acad. Sci. U.S.A. 75, 3173-3177.
31. Steinbrecher, U. P. (1987) Oxidation of human low-density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxidation decomposition products. J. Biol. Chem. 262, 3603-3608.
32. Jurgens, G., Hoff, H. F., Chisolm, G. M., III, and Esterbauer, H. (1987) Modification of human low-density lipoprotein by oxidation: characterization and pathophysiological implications. Chem. Phys. Lipids 45, 315-336.